Private Site Segal Trials Expands Psychedelic Research

Segal Trials was highlighted on ABC-7’s segment “Florida researchers work to understand power of psychedelics to treat mental illness”. As one of the first private research sites conducting psychedelic research, Dr. Rishi Kakar, Medical Director and Chief Scientific Officer shared his expertise in investigating psilocybin assisted psychotherapy for the treatment of depression.

In 2020, Segal Trials developed its Center for Psychedelic and Cannabis Research to meet the growing demands of the transforming psychedelic industry. The center has specialized regulatory experience, custom designed session/dosing rooms and highly trained facilitators, including Dr. Julia Mirer, also featured in the segment, uniquely positioning the company to significantly contribute to the “breakthrough designation” status of psilocybin treatments by the FDA.

For more information on Segal Trials and the Center for Psychedelic and Cannabis Research, visit our website,


Want more information?

Join our

Be the first to know about our new studies! You can unsubscribe at any time.